A single center experience of concomitant administration of sofosbuvir/velpatasvir and amiodarone after heart and lung transplantation

A single center experience of concomitant administration of sofosbuvir/velpatasvir and amiodarone after heart and lung transplantation

The advent of direct-acting antiviral agents (DAA) allows for the utilization of hepatitis C (HCV) viremic donors to uninfected recipients. Sofosbuvir/velpatasvir (SOF/VEL) is a pangenotypic DAA without clinically significant interactions with immunosuppressants, but its concomitant use with amiodar...

Full description

Saved in:
Bibliographic Details
Main Authors: Ryan M. Rivosecchi, Pablo G. Sanchez, Lauren M. Sacha, Edward T. Horn, Mary Keebler, Fernanda P. Silveira
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:JHLT Open
Subjects:
Hepatitis C
Amiodarone
Bradycardia
Heart transplant
Lung transplant
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133425000746
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2950133425000746

Similar Items